Statements

22 Jun 2026

Open letter: Ensuring public return on public investment – Support for access planning and socially responsible innovation provisions in Framework Programme 10 (FP10)

Statements

9 Jun 2026

DNDi Statement at the UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR)

Statements

19 May 2026

DNDi interventions at the 79^th World Health Assembly

Statements

15 May 2026

DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’

Statements

13 May 2026

DNDi’s briefing note for 79^th World Health Assembly

Statements

23 Mar 2026

DNDi statement at the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement

Statements

10 Feb 2026

Statement on Brazil’s draft National Action Plan for Antimicrobial Resistance

Statements

3 Feb 2026

DNDi interventions at the 158^th Session of the WHO Executive Board

Statements

23 Jan 2026

DNDi’s briefing note for 158^th Session of the WHO Executive Board

Statements

13 Nov 2025

Joint statement by CEPI, DNDi, MMV, and Unitaid on the Belém Health Action Plan (BHAP)

Statements

21 Aug 2025

DNDi’s briefing note for the 75^th Session of the World Health Organization Regional Committee for Africa

Statements

27 May 2025

DNDi interventions at the 78^th World Health Assembly

Statements

8 May 2025

DNDi’s briefing note for 78^th World Health Assembly

Statements

16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Statements

12 Feb 2025

DNDi statement on recent US government executive actions and the escalating retreat from global health and medical research

Statements

5 Feb 2025

DNDi interventions at the 156^th Session of the WHO Executive Board